Valkov N I, Gump J L, Sullivan D M
H. Lee Moffitt Cancer Center & Research Institute, Department of Internal Medicine and Biochemistry, University of South Florida, Tampa 33612, USA.
J Cell Biochem. 1997 Oct 1;67(1):112-30. doi: 10.1002/(sici)1097-4644(19971001)67:1<112::aid-jcb12>3.0.co;2-j.
Topo II alpha is considered an important constituent of the nuclear matrix, serving as a fastener of DNA loops to the underlying filamentous scaffolding network. To further define a mechanism of drug resistance to topo II poisons, we studied the quantity of topo II alpha associated with the nuclear matrix in drug-resistant SMR16 and parental cells in the presence and absence of VP-16. Nuclear matrices were prepared from nuclei isolated in EDTA buffer, followed by nuclease digestion with DNase II in the absence of RNase treatment and extraction with 2 M NaCl. Whole-mount spreading of residual structures permits, by means of isoform-specific antibody and colloidal-gold secondary antibodies, an estimate of the amount of topo II alpha in individual nuclear matrices. There are significant variations in topo II alpha amounts between individual nuclear matrices due to the cell cycle distribution. The parental cell line contained eight to ten times more nuclear matrix-associated topo II alpha than the resistant cell line matrices. Nuclear matrix-associated topo II alpha from wild-type and resistant cell lines correlated well with the immunofluorescent staining of the enzyme in nuclei of intact cells. The amount of DNA associated with residual nuclear structures was five times greater in the resistant cell line. This quantity of DNA was not proportional to the quantity of topo II alpha in the same matrix; in fact they were inversely related. In situ whole-mount nuclear matrix preparations were obtained from cells grown on grids and confirmed the results from labeling of isolated residual structures.
拓扑异构酶IIα被认为是核基质的重要组成部分,作为DNA环与下层丝状支架网络的固定物。为了进一步确定对拓扑异构酶II毒药的耐药机制,我们研究了在有和没有依托泊苷(VP - 16)的情况下,耐药性SMR16细胞和亲本细胞中与核基质相关的拓扑异构酶IIα的数量。核基质是由在EDTA缓冲液中分离的细胞核制备而成,随后在无核糖核酸酶处理的情况下用脱氧核糖核酸酶II进行核酸酶消化,并用2M氯化钠进行提取。通过同工型特异性抗体和胶体金二抗,对残余结构进行整装铺展,从而估计单个核基质中拓扑异构酶IIα的量。由于细胞周期分布,单个核基质之间拓扑异构酶IIα的量存在显著差异。亲代细胞系中与核基质相关的拓扑异构酶IIα比耐药细胞系基质中的多八到十倍。野生型和耐药细胞系中与核基质相关的拓扑异构酶IIα与完整细胞核中该酶的免疫荧光染色相关性良好。耐药细胞系中与残余核结构相关的DNA量是其五倍。这种DNA量与同一基质中拓扑异构酶IIα的量不成正比;事实上它们呈负相关。原位整装核基质制剂是从生长在网格上的细胞中获得的,并证实了对分离的残余结构进行标记的结果。